Localization
|
Widespread in the respiratory tract. |
Peritumoral and intratumoral |
[43,44] |
Main characteristics
|
Progressive DNA damage. Accumulation of oncogenic mutations. Inactivation of tumor suppressor genes. |
Epithelial–mesothelial transition activation, heterogenous cellular populations, complex roles in tumorigenesis and acquiring of the hallmarks of cancer by the tumor. |
[25,26,43,45] |
Pathology
|
Adjacent premalignant lesions are identifiable on classic histology. Normal-appearing adjacent tissue might harbor genetic mutations that need further molecular analysis. |
Identifiable with classic histology and with immunohistochemistry for a specific cellular population. |
[46,47] |
Removal
|
Not removed with the primary tumor and can give rise to second tumors. |
Usually removed with the main tumor. |
[48] |
Constituents
|
Normal-appearing cells or premalignant cells of the respiratory tract. |
Immune populations composed mainly of leucocytes and macrophages and stromal populations, including the extracellular matrix, blood vessels and signaling molecules. |
[25,44,45] |
Role(s)
|
Develops due to progressive exposure to stressors and toxins and can progress and give rise to tumors. |
Supports tumor progression and development and creates a tumor sanctuary that promotes proliferation and dissemination. |
[44,45,46,49] |